Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Hepatol. Dec 27, 2012; 4(12): 399-401
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.399
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.399
Estrium Whey induced hepatitis in a patient with metastatic breast cancer: Case report
Maria Jose Velasco, Department of Internal Medicine and Department of Oncology, Luis Vernaza Hospital, Guayaquil, Ecuador and Mayo Clinic College of Medicine, Rochester, MN 55905, United States
Julian Molina, Department of Oncology, Luis Vernaza Hospital, Guayaquil, Ecuador and Mayo Clinic College of Medicine, Rochester, MN EC090112, United States
Author contributions: Velasco MJ carried out the design, and drafted the manuscript; and Molina J participated in the coordination of the manuscript.
Correspondence to: Dr. Maria Jose Velasco, Department of Internal Medicine and Department of Oncology, Luis Vernaza Hospital, Guayaquil, Ecuador and Mayo Clinic College of Medicine, Rochester, MN 55905, United States. ma_jose_velasco@hotmail.com
Telephone: +1-203-7897940 Fax: +1-203-7893007
Received: September 1, 2011
Revised: November 4, 2011
Accepted: November 14, 2012
Published online: December 27, 2012
Revised: November 4, 2011
Accepted: November 14, 2012
Published online: December 27, 2012
Abstract
Estrium Whey is an alternative nutritional support therapy for women. It’s enhanced with specific nutrients including phytoestrogens, folate, antioxidants and fiber to support healthy estrogen detoxification and hormone balance. We describe the first case of hepatotoxicity due to Estrium Whey in a 51-year old female with metastatic breast cancer with clinical, laboratory and histopathological changes.
Keywords: Estrium Whey, Hepatotoxicity, Metastatic disease